Share:

Immunological products, put up in measured doses or in forms or packings for retail sale

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified: > Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes: > Immunological products, put up in measured doses or in forms or packings for retail sale

Duty Rate (from China)

0%
MFN Base RateFree

Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter

Total Effective Rate0%

Products classified under HTS 3002.15.00

Pfizer Prevnar 13 Pneumococcal Vaccine

Prevnar 13 is a 13-valent pneumococcal conjugate vaccine used to prevent invasive disease caused by Streptococcus pneumoniae in infants and adults. It contains purified capsular polysaccharides conjugated to a carrier protein, qualifying as an immunological product under HTS 3002.15.00 due to its measured doses packaged for retail sale in pre-filled syringes.

Moderna Spikevax COVID-19 Vaccine

Spikevax is an mRNA-based COVID-19 vaccine encoding the SARS-CoV-2 spike protein to elicit immune response. As a biotechnologically produced immunological product in pre-filled syringes for retail sale, it fits HTS 3002.15.00.

Merck Gardasil 9 HPV Vaccine

Gardasil 9 vaccine targets nine HPV types with virus-like particles (VLPs) for cervical cancer prevention. As a measured-dose retail product, it falls under immunological products of HTS 3002.15.00.

Bavarian Nordic Imvamune Smallpox Vaccine

Imvamune is a non-replicating modified vaccinia Ankara vaccine for smallpox/mpox protection. Its immunological nature and retail dosing qualify for HTS 3002.15.00.

Seqirus Flucelvax Influenza Vaccine

Flucelvax is cell culture-derived inactivated influenza vaccine with four strains. Packaged in measured doses for retail sale, it's an immunological product under HTS 3002.15.00.

Regeneron Casimvy Gene Therapy

Casimvy uses CRISPR/Cas9 ex vivo to edit CD34+ cells for sickle cell disease, administered as immunological cell therapy. As a measured-dose biotech product for retail, it fits HTS 3002.15.00.

BioNTech Comirnaty COVID-19 Vaccine

Comirnaty is Pfizer's mRNA COVID-19 vaccine in multi-dose vials for retail sale. Its spike protein induction classifies it as an immunological product under HTS 3002.15.00.

Novavax COVID-19 Vaccine Adjuvanted

Novavax protein-based COVID-19 vaccine with Matrix-M adjuvant, in pre-filled syringes for measured retail doses. Classified as immunological product HTS 3002.15.00.

AstraZeneca Vaxzevria COVID-19 Vaccine

Vaxzevria uses chimpanzee adenovirus vector expressing SARS-CoV-2 spike for immunity. Retail multi-dose vials qualify under HTS 3002.15.00 immunological products.

Johnson & Johnson Janssen COVID-19 Vaccine

Janssen single-dose adenovirus type 26 COVID-19 vaccine for adults. Its immunological profile and retail packaging fit HTS 3002.15.00.

Sanofi Dengvaxia Dengue Vaccine

Dengvaxia live attenuated tetravalent dengue vaccine for seropositive individuals. Measured doses in retail packs classify under HTS 3002.15.00.

GSK Menquadfi Meningococcal Vaccine

Menquadfi quadrivalent meningococcal conjugate vaccine against A,C,W,Y serogroups. Prefilled syringes for retail sale under HTS 3002.15.00.

MedImmune FluMist Nasal Influenza Vaccine

FluMist live attenuated influenza vaccine administered intranasally in measured sprayers for retail. As an immunological product, it qualifies for HTS 3002.15.00.

GSK Shingrix Shingles Vaccine

Shingrix is a recombinant zoster vaccine with glycoprotein E antigen and AS01B adjuvant for herpes zoster prevention. Packaged in measured doses for retail, it's an immunological product per HTS 3002.15.00.

Sanofi Menactra Meningococcal Vaccine

Menactra protects against Neisseria meningitidis serogroups A, C, Y, W-135 via polysaccharide-protein conjugates. Its retail syringe packaging for measured doses classifies it under HTS 3002.15.00.